BRAF and melanoma: In melanoma patients treated with BRAF inhibitors a characteristic side effect can be observed with high frequency, development of benign epithelial tumors (keratoacantoma, papilloma) or malignant ones (squamous cancer) (Figure 8) as well as new nevi or induced novel melanomas.